ARTÍCULO DE REVISIÓN
Manejo y prevención de efectos secundarios al empleo de un anticuerpo monoclonal inhibidor de la señal de los receptores del factor de crecimiento epidérmico
Management and prevention of skin side-effects associated with the use of an epidermal growth factor receptor inhibitor monoclonal antibody
Lucia Achell Navaa,
, Sagrario Hierro Orozcoa, Edwin Iván Maya Talamantesb
Autor para correspondencia
luciachell50@hotmail.com
Autor para correspondencia. Av. Félix Cuevas N° 540, Colonia del Valle, Benito Juárez, C.P. 03229, México, D.F., México. Tel.: +52 55 5200 5003.
Autor para correspondencia. Av. Félix Cuevas N° 540, Colonia del Valle, Benito Juárez, C.P. 03229, México, D.F., México. Tel.: +52 55 5200 5003.
Leído
10701
Vecesse ha leído el artículo
1547
Total PDF
9154
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 35 | 3 | 38 |
| 2025 11 | 109 | 24 | 133 |
| 2025 10 | 87 | 13 | 100 |
| 2025 9 | 90 | 18 | 108 |
| 2025 8 | 85 | 23 | 108 |
| 2025 7 | 102 | 5 | 107 |
| 2025 6 | 72 | 7 | 79 |
| 2025 5 | 119 | 10 | 129 |
| 2025 4 | 115 | 6 | 121 |
| 2025 3 | 121 | 8 | 129 |
| 2025 2 | 95 | 8 | 103 |
| 2025 1 | 88 | 4 | 92 |
| 2024 12 | 89 | 5 | 94 |
| 2024 11 | 62 | 8 | 70 |
| 2024 10 | 110 | 12 | 122 |
| 2024 9 | 100 | 11 | 111 |
| 2024 8 | 122 | 9 | 131 |
| 2024 7 | 115 | 16 | 131 |
| 2024 6 | 91 | 12 | 103 |
| 2024 5 | 105 | 9 | 114 |
| 2024 4 | 138 | 7 | 145 |
| 2024 3 | 135 | 7 | 142 |
| 2024 2 | 153 | 24 | 177 |
| 2024 1 | 128 | 16 | 144 |
| 2023 12 | 125 | 38 | 163 |
| 2023 11 | 171 | 19 | 190 |
| 2023 10 | 192 | 20 | 212 |
| 2023 9 | 143 | 10 | 153 |
| 2023 8 | 139 | 13 | 152 |
| 2023 7 | 109 | 11 | 120 |
| 2023 6 | 122 | 16 | 138 |
| 2023 5 | 205 | 19 | 224 |
| 2023 4 | 139 | 6 | 145 |
| 2023 3 | 113 | 5 | 118 |
| 2023 2 | 91 | 6 | 97 |
| 2022 1 | 115 | 3 | 118 |
| 2022 12 | 67 | 14 | 81 |
| 2022 11 | 94 | 8 | 102 |
| 2022 10 | 93 | 18 | 111 |
| 2022 9 | 98 | 17 | 115 |
| 2022 8 | 94 | 20 | 114 |
| 2022 7 | 48 | 9 | 57 |
| 2022 6 | 71 | 12 | 83 |
| 2022 5 | 54 | 15 | 69 |
| 2022 4 | 67 | 13 | 80 |
| 2022 3 | 84 | 17 | 101 |
| 2022 2 | 84 | 13 | 97 |
| 2021 1 | 127 | 24 | 151 |
| 2021 12 | 110 | 20 | 130 |
| 2021 11 | 114 | 20 | 134 |
| 2021 10 | 124 | 15 | 139 |
| 2021 9 | 107 | 17 | 124 |
| 2021 8 | 98 | 9 | 107 |
| 2021 7 | 61 | 7 | 68 |
| 2021 6 | 68 | 11 | 79 |
| 2021 5 | 100 | 11 | 111 |
| 2021 4 | 175 | 54 | 229 |
| 2021 3 | 122 | 18 | 140 |
| 2021 2 | 64 | 10 | 74 |
| 2020 1 | 86 | 22 | 108 |
| 2020 12 | 90 | 13 | 103 |
| 2020 11 | 79 | 9 | 88 |
| 2020 10 | 48 | 10 | 58 |
| 2020 9 | 89 | 22 | 111 |
| 2020 8 | 53 | 21 | 74 |
| 2020 7 | 49 | 12 | 61 |
| 2020 6 | 51 | 29 | 80 |
| 2020 5 | 59 | 18 | 77 |
| 2020 4 | 42 | 6 | 48 |
| 2020 3 | 48 | 14 | 62 |
| 2020 2 | 62 | 20 | 82 |
| 2020 1 | 41 | 13 | 54 |
| 2019 12 | 38 | 11 | 49 |
| 2019 11 | 37 | 11 | 48 |
| 2019 10 | 37 | 10 | 47 |
| 2019 9 | 54 | 6 | 60 |
| 2019 8 | 38 | 6 | 44 |
| 2019 7 | 43 | 11 | 54 |
| 2019 6 | 85 | 13 | 98 |
| 2019 5 | 162 | 20 | 182 |
| 2019 4 | 130 | 37 | 167 |
| 2019 3 | 29 | 7 | 36 |
| 2019 2 | 29 | 16 | 45 |
| 2019 1 | 22 | 18 | 40 |
| 2018 12 | 32 | 9 | 41 |
| 2018 11 | 40 | 16 | 56 |
| 2018 10 | 38 | 18 | 56 |
| 2018 9 | 35 | 8 | 43 |
| 2018 8 | 55 | 10 | 65 |
| 2018 7 | 41 | 2 | 43 |
| 2018 6 | 33 | 2 | 35 |
| 2018 5 | 44 | 23 | 67 |
| 2018 4 | 46 | 3 | 49 |
| 2018 3 | 36 | 5 | 41 |
| 2018 2 | 22 | 6 | 28 |
| 2018 1 | 18 | 2 | 20 |
| 2017 12 | 21 | 3 | 24 |
| 2017 11 | 33 | 2 | 35 |
| 2017 10 | 24 | 1 | 25 |
| 2017 9 | 26 | 6 | 32 |
| 2017 8 | 19 | 3 | 22 |
| 2017 7 | 49 | 3 | 52 |
| 2017 6 | 38 | 14 | 52 |
| 2017 5 | 48 | 12 | 60 |
| 2017 4 | 33 | 32 | 65 |
| 2017 3 | 42 | 52 | 94 |
| 2017 2 | 99 | 8 | 107 |
| 2016 1 | 32 | 1 | 33 |
| 2016 12 | 40 | 4 | 44 |
| 2016 11 | 52 | 5 | 57 |
| 2016 10 | 68 | 10 | 78 |
| 2016 9 | 101 | 11 | 112 |
| 2016 8 | 69 | 8 | 77 |
| 2016 7 | 42 | 7 | 49 |
| 2016 6 | 55 | 43 | 98 |
| 2016 5 | 47 | 29 | 76 |
| 2016 4 | 21 | 11 | 32 |
Mostrar todo